BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 25263941)

  • 1. Gene body methylation can alter gene expression and is a therapeutic target in cancer.
    Yang X; Han H; De Carvalho DD; Lay FD; Jones PA; Liang G
    Cancer Cell; 2014 Oct; 26(4):577-90. PubMed ID: 25263941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.
    Habano W; Gamo T; Terashima J; Sugai T; Otsuka K; Wakabayashi G; Ozawa S
    BMC Cancer; 2011 Feb; 11():81. PubMed ID: 21342487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines.
    Fang JY; Lu J; Chen YX; Yang L
    World J Gastroenterol; 2003 Sep; 9(9):1976-80. PubMed ID: 12970888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
    Chen M; Zhang J; Li N; Qian Z; Zhu M; Li Q; Zheng J; Wang X; Shi G
    PLoS One; 2011; 6(10):e25564. PubMed ID: 22039417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
    Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation.
    Long Y; Tsai WB; Chang JT; Estecio M; Wangpaichitr M; Savaraj N; Feun LG; Chen HH; Kuo MT
    Oncotarget; 2016 Dec; 7(50):82658-82670. PubMed ID: 27765932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
    Meng CF; Dai DQ; Guo KJ
    Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells.
    Chen J; Ding J; Wang Z; Zhu J; Wang X; Du J
    Oncotarget; 2017 Mar; 8(12):19609-19630. PubMed ID: 28121627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Basato S; Brun P; Angriman I; Castoro C
    BMC Cancer; 2016 Jul; 16():388. PubMed ID: 27377375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effects of DNA methyltransferase 3B depletion are not associated with DNA demethylation.
    Hagemann S; Kuck D; Stresemann C; Prinz F; Brueckner B; Mund C; Mumberg D; Sommer A
    PLoS One; 2012; 7(5):e36125. PubMed ID: 22563479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between T-cadherin gene expression and aberrant methylation of T-cadherin promoter in human colon carcinoma cells.
    Ren JZ; Huo JR
    Med Oncol; 2012 Jun; 29(2):915-8. PubMed ID: 21298366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Promoter methylation status of SFRP genes and induced apoptosis by demethylation in Jurkat cells].
    Xu C; Shen J; Liao B; Fu H; Zhou H; Qi Y; Huangfu Z; Chen Y; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):51-5. PubMed ID: 26876254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative promoters within gene bodies control exon expression via TET1-mediated H3K36 methylation.
    Ma L; Muhammad T; Wang H; Du G; Sakhawat A; Wei Y; Ali Khan A; Cong X; Huang Y
    J Cell Physiol; 2020 Oct; 235(10):6711-6724. PubMed ID: 31994732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
    Côté S; Sinnett D; Momparler RL
    Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.